A straightforward blood-based assessment developed at the Institute of Science Tokyo, Japan, can help assess how effectively high-density lipoprotein (HDL) removes cholesterol from blood vessel walls, a function known as cholesterol efflux capacity (CEC). The study linked low CEC to high-risk coronary plaque, supporting the broader clinical use of this method for predicting cardiovascular risk and improving preventive strategies.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗